Physician profile
Omar Iqbal
NPI 1508397613
$10,705.47
in general payments reported to CMS, 2019-2025
18 companies · $68.12 in 2025
The $68.12 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $172 · 2021: $324 · 2022: $183 · 2023: $8,815 · 2024: $203 · 2025: $68.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,426 · Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,426.22 |
| Food and Beverage | $659.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $8,514.95 | 2023 | |
| Alcon Vision LLC | $806.16 | 2019-2021 | |
| Genentech USA, INC. | $288.83 | 2022-2025 | Vabysmo |
| Baxter Healthcare | $282.77 | 2019-2020 | |
| Abiomed | $147.34 | 2024 | Impella |
| Horizon Therapeutics Plc | $119.37 | 2022 | |
| Alimera Sciences, INC. | $113.43 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $100.00 | 2021 | |
| Astellas Pharma US INC | $72.82 | 2023-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $57.22 | 2023-2024 | Eylea Hd, Dupixent |
| Sight Sciences, INC. | $46.07 | 2019 | |
| Allergan, INC. | $34.95 | 2020 | |
| Nuvasive, INC. | $30.01 | 2021 | |
| Abbvie INC. | $24.93 | 2025 | |
| Glaukos Corporation | $19.66 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $18.69 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.41 | 2020 | |
| Globus Medical, INC. | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.